Latest Artemisinin Stories
NSF-supported researchers use synthetic biology technology to engineer the next generation of biofuels.
Doctors should ask patients if they are taking herbal supplements because of potential interaction with medications, U.S.
A new study suggests that scientists may finally be on the right track to developing an effective vaccine against malaria, one of mankindâ€™s top killers.
Malaria parasites in western Cambodia have become resistant to artemisinin-based therapies, the first-line treatment for malaria, according to a study published in the New England Journal of Medicine today. Resistance to the drugs makes them less effective and could eventually render them obsolete, putting millions of lives at risk.
A new subsidy designed to increase access to life-saving antiretrovirals must remain focused on quality patient care if it is to succeed, argues Tido von Schoen-Angerer and colleagues in this week's open access journal PLoS Medicine.
Eliminating polio everywhere will require global cooperation on several fronts, including lowering the cost for poor countries to vaccinate with inactivated polio vaccine
Current combination malaria therapies recommended by the World Health Organization (WHO) provide adequate treatment for mild malaria, according to a Cochrane Systematic Review of the evidence.
Malaria's resistance to treatment in western Cambodia could foretell a global health crisis, a British researcher said. Malaria in western Cambodia is proving resistant to the artemesinin family of drugs, until now the world's most effective drugs for treating the illness, said Nick Day, director of the Mahidol-Oxford Tropical Medicine Research Unit. In recent trials, it took up to five days to clear patients' blood of malaria parasites when the drugs previously worked in two or three days,...
The first evidence of resistance to the world's most effective drug for treating malaria has been found by international scientists.
Methylene blue can curb the spread of malaria parasites when administered together with new malaria medication / Heidelberg researchers publish in PLoS One.
- A person in a secondary role, specifically the second most important character (after the protagonist).